EMN Stock Cash Flow Statements

Eastman Chemical Quarterly Cash Flow Statements Chart

Quarterly

Annual

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Eastman Chemical Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31	2002-12-31

operating activities
net earnings	331,000,000	311,000,000	2,000,000	380,000,000	34,000,000	27,000,000	35,000,000	491,000,000	118,000,000	125,000,000				100,000,000	19,000,000	-32,000,000	-2,000,000	98,000,000		66,000,000
adjustments to reconcile net earnings to net cash from operating activities:
depreciation and amortization	129,000,000	118,000,000	117,000,000	122,000,000	145,000,000	149,000,000	153,000,000	147,000,000	144,000,000	142,000,000	122,000,000	107,000,000	108,000,000	69,000,000	68,000,000	71,000,000	68,000,000	80,000,000		75,000,000
benefit from deferred income taxes	24,000,000	54,000,000	-82,000,000	28,000,000		10,000,000	-66,000,000		88,000,000	78,000,000	41,000,000		-15,000,000
changes in operating assets and liabilities, net of effect of acquisitions and divestitures:
increase in trade receivables	182,000,000	58,000,000	204,000,000	158,000,000	59,000,000	220,000,000	245,000,000	135,000,000	76,000,000	168,000,000	137,000,000	81,000,000	111,000,000	74,000,000	39,000,000	37,000,000
increase in inventories	-122,000,000	54,000,000	119,000,000	-20,000,000	-25,000,000	42,000,000	37,000,000	72,000,000		-3,000,000	15,000,000	8,000,000	8,000,000	69,000,000	-60,000,000	-41,000,000	75,000,000	65,000,000		31,000,000
increase in trade payables	152,000,000	173,000,000	-127,000,000	177,000,000	113,000,000	156,000,000	83,000,000	143,000,000		37,000,000	-18,000,000	65,000,000	-3,000,000	-85,000,000	96,000,000		-162,000,000	111,000,000
pension and other postretirement contributions (in excess of) less than expenses	-12,000,000	-27,000,000	-34,000,000	-43,000,000	-28,000,000	-22,000,000				-112,000,000	-89,000,000		235,000,000
variable compensation payments (in excess of) less than expenses	55,000,000	69,000,000
other items	-145,000,000	-73,000,000	172,000,000	-186,000,000	-98,000,000	-179,000,000	120,000,000	123,000,000	-127,000,000	-39,000,000	-107,000,000	-68,000,000	-25,000,000	78,000,000	-25,000,000	-41,000,000	107,000,000	-25,000,000		11,000,000
net cash from operating activities	540,000,000	452,000,000	457,000,000	430,000,000	406,000,000	671,000,000	740,000,000	646,000,000	394,000,000	562,000,000	459,000,000	503,000,000	440,000,000	352,000,000	278,000,000	90,000,000	360,000,000	321,000,000		395,000,000
investing activities
additions to properties and equipment	-179,000,000	-179,000,000	-203,000,000	-240,000,000	-105,000,000	-117,000,000	-147,000,000	-211,000,000	-251,000,000	-226,000,000	-187,000,000	-171,000,000	-168,000,000	-124,000,000	-110,000,000	-42,000,000	-204,000,000	-172,000,000		-119,000,000
government incentives
net cash from investing activities	-132,000,000	248,000,000	-206,000,000	418,000,000	-112,000,000	-120,000,000	-148,000,000	-213,000,000	-296,000,000	-226,000,000	-3,373,000,000	-149,000,000	-167,000,000	-126,000,000	-119,000,000	-56,000,000	-231,000,000			-248,000,000
financing activities
net increase in commercial paper and other borrowings		-399,000,000	-29,000,000	0	-135,000,000	-219,000,000	-485,000,000	-90,000,000
proceeds from borrowings	0	0	0		0	125,000,000	1,114,000,000	75,000,000	1,041,000,000	0	2,950,000,000	0	0
repayment of borrowings	0	0	0		-185,000,000	-375,000,000	-1,081,000,000	-275,000,000	-1,169,000,000	-275,000,000	0	-300,000,000	-200,000,000			-85,000,000	0			0
dividends paid to stockholders	-94,000,000	-94,000,000	-91,000,000	-93,000,000	-89,000,000	-85,000,000	-78,000,000	-73,000,000	-68,000,000	-59,000,000	-51,000,000	-46,000,000	-85,000,000	-36,000,000	-31,000,000	-32,000,000	-32,000,000	-35,000,000		-36,000,000
treasury stock purchases	-100,000,000	-100,000,000	-100,000,000	-710,000,000	0	0	-25,000,000	-75,000,000	-25,000,000	-55,000,000	0	-125,000,000		-24,000,000	-212,000,000		0	-82,000,000
net cash from financing activities	-181,000,000	-593,000,000	-223,000,000	-1,106,000,000	-382,000,000	-556,000,000	-558,000,000	-438,000,000	-121,000,000	-351,000,000	2,915,000,000	-342,000,000	-261,000,000	-97,000,000	-285,000,000	92,000,000	-80,000,000			96,000,000
effect of exchange rate changes on cash and cash equivalents	-12,000,000	2,000,000	4,000,000	0	2,000,000	2,000,000	-1,000,000	1,000,000	-3,000,000	-1,000,000	1,000,000	3,000,000	0	0	0				-1,000,000
net change in cash and cash equivalents	215,000,000	109,000,000	32,000,000	-258,000,000	-86,000,000	-3,000,000	33,000,000	-4,000,000	-26,000,000	-16,000,000	2,000,000	15,000,000	12,000,000	129,000,000	-126,000,000	125,000,000	50,000,000	107,000,000	509,000,000	238,000,000	146,000,000	505,000,000
cash and cash equivalents at beginning of period	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0		0
cash and cash equivalents at end of period	215,000,000	109,000,000	32,000,000	-258,000,000	-86,000,000	-3,000,000	33,000,000	-4,000,000	-26,000,000	-16,000,000	2,000,000	15,000,000	12,000,000	129,000,000	-126,000,000	125,000,000	50,000,000	107,000,000	509,000,000	238,000,000	146,000,000	505,000,000	-11,000,000
mark-to-market pension and other postretirement benefit plans (gain) loss			22,000,000
asset impairment charges	0			11,000,000	1,000,000					0	2,000,000	22,000,000	37,000,000
(gain) loss on sale of assets
(gain) loss on divested businesses
proceeds from sale of businesses		418,000,000	0
acquisitions, net of cash acquired			0	-3,000,000		0		0	0
acquisition, net of cash acquired
additions to capitalized software		-1,000,000	-3,000,000	-5,000,000							-1,000,000	-3,000,000	-1,000,000				-2,000,000
net decrease in commercial paper and other borrowings
mark-to-market pension and other postretirement benefit plans gain
early debt extinguishment costs					0															0
mark-to-market pension and other postretirement benefit plans (gain)
loss on sale of assets			0
gain on divested business
proceeds from stock option exercises and other items								2,000,000	-5,000,000	0	21,000,000	4,000,000	28,000,000	-37,000,000	77,000,000	2,000,000	1,000,000	3,000,000		9,000,000
loss on divested businesses
(gain) loss on divested business
variable compensation (in excess of) less than expenses					62,000,000	53,000,000				51,000,000	35,000,000	52,000,000
income from sale of business
proceeds from sale of business
loss on business held for sale
gain from sale of assets
gain from property insurance							0
proceeds from property insurance							0
proceeds from sale of assets and businesses
(benefit from) benefit from deferred income taxes
early debt extinguishment and other related costs
gains from sale of assets and businesses
dividends paid to noncontrolling interest
pension and other postretirement contributions in excess of expenses									-208,000,000
variable compensation less than expenses
dividends paid to noncontrolling interests
gain from sale of business
proceeds from sale of business and assets
proceeds from sale of assets																				0
gains from sale of businesses								0
proceeds from sale of businesses and assets								0
mark-to-market loss on pension and other postretirement benefit plans									67,000,000
gain on sale of equity investment
gains on sale of assets																	-1,000,000
decrease (increase) in inventories
decrease in trade payables
proceeds from sale of assets and equity investment
net increase in commercial paper borrowings
benefit for deferred income taxes																20,000,000	-15,000,000			-15,000,000
decrease in inventories
variable compensation in excess of expenses
mark-to-market (gain) loss on pension and other postretirement benefit plans
proceeds from sale of assets and investments												25,000,000	0	0	2,000,000			159,000,000
acquisitions and investments in joint ventures, net of cash acquired													-1,000,000
gain on sale of assets
cash flows from operating activities
cash flows from investing activities
cash flows from financing activities
net earnings including noncontrolling interest												349,000,000
proceeds from redemption of short-term time deposits													0
mark-to-market gain on pension and other postretirement benefit plans
additions to short-term time deposits														0
net increase in commercial paper, credit facility, and other borrowings												125,000,000	0	0	1,000,000
mark-to-market pension and other post-employment benefits (gain) loss
pension and other post-employment contributions (in excess of) less than expenses
acquisitions and investments in joint ventures														-2,000,000	-1,000,000
proceeds from sale of short-term time deposits
asset impairments charges
increase in liabilities for employee benefits and incentive pay														18,000,000	11,000,000	-127,000,000	13,000,000			45,000,000
acquisitions of and investments in joint ventures
net increase in commercial paper, credit facility and other borrowings
acquisitions of joint ventures
investments in joint ventures
proceeds from sale of investments
net decrease in commercial paper, credit facility, and other borrowings
asset impairments																		0		11,000,000
changes in operating assets and liabilities:
increase in receivables
investments in and acquisitions of joint ventures
income from equity investment in genencor																				0
proceeds from the sale of equity investment in genencor
proceeds from long-term borrowings
repayment of long-term borrowings
provision (benefits) for deferred income taxes
(decrease) in liabilities for employee benefits and incentive pay
net cash (used in) investing activities
net cash (used in) financing activities
net cash provided by:
proceeds from sale of equity investment in genencor																				0
net increase in commercial paper, credit facility and other short-term borrowings
decrease in liabilities for employee benefits and incentive pay
cumulative effect of change in accounting principles
loan to joint venture
net increase in commercial paper, credit facility, and other short-term borrowings
cumulative effect of changes in accounting principles
gain on sales of assets
changes in operating assets and liabilities, net of divestitures:
proceeds from sales of assets
net decrease in commercial paper, credit facility, and other short-term borrowings
net cash provided by
changes in operating assets and liabilities, net of effect of acquisitions:
net decrease in commercial paper and other short-term borrowings
adjustments to reconcile net earnings to net cash from operating activities, net of effect of acquisitions
other investments
proceeds from sales of fixed assets
net increase in commercial paper and other short-term borrowings
stock options and other items
net increase in commercial paper and short-term borrowings

We provide you with 20 years of cash flow statements for Eastman Chemical stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Eastman Chemical stock. Explore the full financial landscape of Eastman Chemical stock with our expertly curated income statements.

The information provided in this report about Eastman Chemical stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.